Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation

被引:22
|
作者
Balci, Kevser Gulcihan [1 ]
Balci, Mustafa Mucahit [1 ]
Canpolat, Ugur [1 ]
Sen, Fatih [1 ]
Akboga, Mehmet K. [1 ]
Suleymanoglu, Muhammed [1 ]
Kuyumcu, Serdar [1 ]
Maden, Orhan [1 ]
Selcuk, Hatice [1 ]
Selcuk, Mehmet Timur [1 ]
机构
[1] Turkiye Yuksek Ihtisas Res & Educ Hosp, Dept Cardiol, Ankara, Turkey
关键词
atrial fibrillation; warfarin; apixaban; dabigatran; quality of life; anxiety; HOSPITAL ANXIETY; DEPRESSION; GUIDELINES; MANAGEMENT; VALIDITY; THERAPY; DISEASE; IMPACT;
D O I
10.5152/AnatolJCardiol.2015.6334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study was to compare health-related quality of life (HRQoL) measures between novel oral anticoagulants (NOACs) and warfarin-treated Turkish patients who had been started on oral anticoagulants (OACs) due to non-valvular atrial fibrillation (AF) and to determine the effects of OACs on patient's emotional status, anxiety and depression. Methods: A total of 182 patients older than 18 years with non-valvular AF and being treated with OACs for at least 6 months according to current AF guidelines who were admitted to outpatient clinics between July 2014 and January 2015 were included in this cross-sectional study. The exclusion criteria were receiving OACs for conditions other than non-valvular AF and being unable to answer the questionnaire. A questionnaire was administered to all participants to evaluate HRQoL, depression and anxiety. The mean differences between the groups were compared using Student's t-test; the Mann-Whitney U test was applied for comparisons of the medians. Results: The annual number of hospital admissions was significantly higher in the warfarin group (p<0.001), and all HRQoL scores were significantly lower and Hospital Anxiety and Depression Scale (HADS) score was higher in the warfarin group (p<0.001). History of any type of bleeding was significantly higher in the warfarin group (p<0.001). However, none of the patients had major bleeding. Among patients who experienced bleeding, all HRQoL scores were significantly lower and HADS score was significantly higher (p<0.001 and p=0.002, respectively). Conclusion: Warfarin-treated patients had higher levels of self-reported symptoms of depression and anxiety and compromised HRQoL when compared with NOAC-treated patients. The results may be explained by higher rates of bleeding episodes and higher number of hospital admissions, which may cause restrictions in life while on warfarin treatment.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 50 条
  • [21] Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Bura-Riviere, Alessandra
    Maury, Philippe
    Calmels, Violaine
    Sallerin, Brigitte
    Pathak, Atul
    Montastruc, Jean-Louis
    Bagheri, Haleh
    THERAPIE, 2015, 70 (06): : 485 - 492
  • [22] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Hwang, Ki Won
    Choi, Jin Hee
    Lee, Soo Yong
    Lee, Sang Hyun
    Chon, Min Ku
    Lee, Jungkuk
    Kim, Hasung
    Kim, Yong-Giun
    Choi, Hyung Oh
    Kim, Jeong Su
    Park, Yong-Hyun
    Kim, June Hong
    Chun, Kook Jin
    Nam, Gi-Byoung
    Choi, Kee-Joon
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [23] Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry
    Navarro-Almenzar, Begona
    Jose Cerezo-Manchado, Juan
    Caro-Martinez, Cesar
    Garcia-Candel, Faustino
    Flores Blanco, Pedro Jose
    Elvira Ruiz, Gines
    Andreu Cayuelas, Jose Miguel
    Arregui Montoya, Francisco
    Cascales, Almudena
    Lova Navarro, Alejandro
    Garcia Alberola, Arcadio
    Pascual Figal, Domingo Andres
    Bailen Lorenzo, Jose Luis
    Manzano-Fernandez, Sergio
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2035 - 2041
  • [24] Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
    Amin, Alpesh
    Keshishian, Allison
    Dina, Oluwaseyi
    Dhamane, Amol
    Nadkarni, Anagha
    Carda, Eric
    Russ, Cristina
    Rosenblatt, Lisa
    Mardekian, Jack
    Yuce, Huseyin
    Baker, Christine L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 240 - 249
  • [25] Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
    Alpesh Amin
    Allison Keshishian
    Oluwaseyi Dina
    Amol Dhamane
    Anagha Nadkarni
    Eric Carda
    Cristina Russ
    Lisa Rosenblatt
    Jack Mardekian
    Huseyin Yuce
    Christine L. Baker
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 240 - 249
  • [26] Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
    Capodanno, Davide
    Capranzano, Piera
    Giacchi, Giuseppe
    Calvi, Valeria
    Tamburino, Corrado
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1237 - 1241
  • [27] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [28] Analysis of the influence of thromboembolic complications prevention with oral anticoagulants on budget in patients with non-valvular atrial fibrillation
    Rudakova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (03) : 267 - 271
  • [29] Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution
    Tagaya, Manaka
    Yoshikawa, Daiji
    Sugishita, Yoshinori
    Yamauchi, Fumi
    Ito, Takehiro
    Kamada, Tomohito
    Yoshinaga, Masataka
    Mukaide, Daisuke
    Fujiwara, Wakaya
    Yokoi, Hiroatsu
    Hayashi, Mutsuharu
    Watanabe, Eiichi
    Ishii, Junichi
    Ozaki, Yukio
    Izawa, Hideo
    HEART AND VESSELS, 2016, 31 (06) : 957 - 962
  • [30] Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 405 - 414